In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems ...

Abuse of Mephentermine Sulphate injections can lead to various adverse effects, including cardiovascular disorders, and may ...

Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

While relatively rare, cardiac doctors in San Francisco see it again and again: young people hospitalized with a deadly heart ...

Animal studies show hope of an effective and safe treatment for the chronic liver condition affecting 25 percent of US adults ...

Reducing industrial animal use can help to shrink our carbon footprint and boost health—but doing so means we need nutritious ...

When the human body gets hurt, most tissues heal—skin closes over a wound, bone heals itself. But not all organs heal that ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Two everyday medications, pemafibrate and telmisartan, could offer a safer, faster route to treating fatty liver disease.

Funded entirely by taxpayer dollars, this first-of-its-kind drug targets cellular metabolism to promote tissue repair of ...